Waheed Nadia (CIK 2023884) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Sell OCUL (14,828 shares), Sell OCUL (3,510 shares), Sell OCUL (7,863 shares), Buy OCUL (79,112 shares), Buy OCUL (40,363 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Sell | 14,828 | $122,628 |
| 2026-02-24 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Sell | 3,510 | $27,167 |
| 2026-02-17 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Sell | 7,863 | $71,082 |
| 2026-01-06 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Buy | 79,112 | $0 |
| 2025-08-14 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Buy | 40,363 | $0 |
| 2025-06-03 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Sell | 13,861 | $111,581 |
| 2025-02-13 | OCULAR THERAPEUTIX, INC (OCUL) | Chief Medical Officer | Buy | 79,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05